相关实验视频
Updated: Jun 20, 2026

18:11
Microfluidic Chips Controlled with Elastomeric Microvalve Arrays
Published on: October 1, 2007
21.1K
可编程光切换微囊可从微流体进行精确和定制的药物输送
Buyun Guo1,2, Tianao Chen3,4, Xianglong Hu3,4
1Department of Precision Machinery and Precision Instrumentation, University of Science and Technology of China, Hefei, Anhui 230026, China.
ACS applied materials & interfaces
|January 24, 2024
概括
研究人员开发了可光切换的微囊 (PMC),用于精确的药物输送. 这些智能材料使用紫外线可见光提供受控释放,显示了针对癌症治疗和栓塞的前景.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 精准医学需要先进的药物输送系统,可以在时间,空间和剂量上进行控制.
- 响应刺激的智能材料越来越多地用于有针对性的药物输送.
- 通过微流体制造的响应型微囊显示出显著的潜力.
研究的目的:
- 开发UV可见光循环介导的可光切换微囊 (PMCs),用于精确,定制的药物释放.
- 调查PMCs用于控制治疗剂输送的动态透性切换能力.
- 为了证明PMCs在可模式化癌细胞治疗中的治疗效果.
主要方法:
- 使用可编程脉冲空气动力学打印 (PPAP) 制造PMC.
- 在PLGA外内封装磁纳米粒子和多克索鲁比 (DOX).
- 利用紫外线和可见光循环控制药物释放和磁场去除.
主要成果:
- PMCs显示出高精度的时间,空间和剂量控制的 doxorubicin 释放.
- 为药物释放模式开发了一种经过实验验证的理论模型.
- 通过紫外线辐射激活的有效模式癌细胞治疗被证明.
- 在处理后,PMCs被外部磁场成功地去除.
结论:
- PMCs为量身定制的药物输送和栓塞治疗提供了一个多功能平台.
- 该技术整合了栓塞,按需药物输送,磁性启动和成像特性.
- 对于未来的定制可编程药物释放应用和癌症治疗,PMC具有前景.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

